Clinical Trial Update: An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035) [Phase 1]

View source ↗

Summary

An open-label, single-dose safety study of quadrivalent HPV vaccine in Chinese female subjects has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HPV Infections | Phase 1 | Status: COMPLETED | Results posted: 2009-08-20